The Effect of Teprotumumab on Ocular Surface Symptoms in Thyroid Eye Disease

被引：0
|
作者：
Cale, Mario [1 ]
Osias, Ethan [1 ]
Singh, Pallavi [1 ]
Rootman, Daniel [1 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Orbital & Ophthalm Plast Surg, Los Angeles, CA 90095 USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2022年 / 63卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
3997 - A03
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Teprotumumab in thyroid eye disease: wonder drug or great divider?
    Perros, Petros
    Hegedus, Laszlo
    EUROPEAN THYROID JOURNAL, 2023, 12 (04)
  • [42] Facial and Eyelid Changes in Thyroid Eye Disease Are Reversed by Teprotumumab
    Ugradar, Shoaib
    Braun, Jenna
    Wang, Yao
    Zimmerman, Erin
    Douglas, Raymond S.
    PLASTIC AND RECONSTRUCTIVE SURGERY-GLOBAL OPEN, 2021, 9 (09) : E3809
  • [43] Teprotumumab for thyroid eye disease: early response is not required for benefit
    Shoaib Ugradar
    Yao Wang
    Tunde Mester
    George J. Kahaly
    Raymond S. Douglas
    Eye, 2022, 36 : 1403 - 1408
  • [44] Evaluation of the efficacy, safety, and durability of teprotumumab in thyroid eye disease
    Mechels, Keegan
    Hwang, Catherine
    Perry, Julian
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [45] Reactivation After Teprotumumab Treatment for Active Thyroid Eye Disease
    Hwang, Catherine J.
    Rebollo, Nicole P.
    Mechels, Keegan B.
    Perry, Julian D.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2024, 263 : 152 - 159
  • [46] Reply Re: "Teprotumumab for the Treatment of Recalcitrant Thyroid Eye Disease"
    Men, Clara J.
    Amarikwa, Linus
    Pham, Brandon
    Sears, Connie
    Clauss, Kevin
    Lee, Bradford W.
    Lee, Wendy W.
    Pasol, Joshua
    Ugradar, Shoaib
    Shinder, Roman
    Cockerham, Kimberly
    Wester, Sara
    Douglas, Raymond
    Kossler, Andrea Lora
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2025, 41 (01): : 111 - 112
  • [47] Perspective on the Current Role of Teprotumumab in Treatment of Thyroid Eye Disease
    Allen, Richard C.
    Bradley, Elizabeth A.
    Fante, Robert G.
    Lucarelli, Mark J.
    OPHTHALMOLOGY, 2021, 128 (08) : 1125 - 1128
  • [48] Hearing Dysfunction After Treatment With Teprotumumab for Thyroid Eye Disease
    Sears, Connie M.
    Azad, Amee D.
    Amarikwa, Linus
    Pham, Brandon H.
    Men, Clara J.
    Kaplan, Daniel N.
    Liu, Jocelyn
    Hoffman, Andrew R.
    Swanson, Austin
    Alyono, Jennifer
    Lee, Jennifer Y.
    Dosiou, Chrysoula
    Kossler, Andrea L.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2022, 240 : 1 - 13
  • [49] The role of teprotumumab in chronic, clinically active thyroid eye disease
    Caroline Y. Yu
    Brittany A. Simmons
    Chau M. Pham
    Erin M. Shriver
    Eye, 2022, 36 : 1500 - 1501
  • [50] Teprotumumab improves light sensitivity in patients with thyroid eye disease
    Parunakian, Emanuil
    Ugradar, Shoaib
    Tolentino, Joseph
    Malkhasyan, Emil
    Raika, Pershanjit
    Ghaly, Joseph
    Bisht, Chirag
    Douglas, Raymond S.
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2024, 262 (09) : 2999 - 3006
12345